论文信息 - Secukinumab in Moderate-to-Severe Hidradenitis Suppurativa: Primary Endpoint Analysis from the SUNSHINE and SUNRISE Phase III Trials - 字舞流文

Secukinumab in Moderate-to-Severe Hidradenitis Suppurativa: Primary Endpoint Analysis from the SUNSHINE and SUNRISE Phase III Trials

A. Gottlieb | L. Uhlmann | G. Jemec | D. Keefe | M. Woźniak | Elisa Muscianisi | A. Alavi | R. Martin | H. Boreham | Xiaoling Wei | Angela Llobet Martinez | Li Chen